{"disease":{"id":"lupus-nephritis","name":"lupus nephritis"},"drugs":{"marketed":[{"drug_id":"prednison","indication_name":"Diffuse Proliferative Lupus Nephritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"prednisone","indication_name":"Diffuse Proliferative Lupus Nephritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06927219","title":"Research Accelerated by You Lupus Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Lupus Foundation of America","has_results":false},{"nct_id":"NCT06682507","title":"High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT01410747","title":"A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03791827","title":"Multicenter Registry of Pediatric Lupus Nephritis in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Xiqiang Dang","has_results":false},{"nct_id":"NCT03201406","title":"Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":837,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT01714817","title":"Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":695,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT05126277","title":"Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":462,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT01639339","title":"Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Human Genome Sciences Inc., a GSK Company","has_results":true},{"nct_id":"NCT07053891","title":"LUPKYNIS Drug-use Results Survey","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04894695","title":"Urine Exosomes to Identify Biomarkers for LN","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT00626197","title":"A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":381,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT05138133","title":"Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":359,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03021499","title":"Aurinia Renal Response in Active Lupus With Voclosporin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Aurinia Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT06711887","title":"Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":315,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02457221","title":"A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Astellas Pharma China, Inc.","has_results":false},{"nct_id":"NCT06527872","title":"Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04181762","title":"Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":275,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04221477","title":"A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":271,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05443516","title":"Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT05268289","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03580291","title":"Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":230,"lead_sponsor_name":"Lingyun Sun","has_results":false},{"nct_id":"NCT05337124","title":"A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US","phase":"","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Aurinia Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT05495893","title":"MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":224,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT05916781","title":"Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Chinese SLE Treatment And Research Group","has_results":false},{"nct_id":"NCT03597464","title":"Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Aurinia Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT06581198","title":"A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":179,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04643470","title":"Zanubrutinib in Participants With Active Proliferative Lupus Nephritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"BeiGene","has_results":false},{"nct_id":"NCT04266860","title":"Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Qure Healthcare, LLC","has_results":false},{"nct_id":"NCT06155604","title":"SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT02547922","title":"Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT02630628","title":"Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT02550652","title":"A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03687138","title":"Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques","phase":"","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Natalia A. Rivera García","has_results":false},{"nct_id":"NCT04564339","title":"Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":123,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05195086","title":"A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Nada Magdy Mansour","has_results":false},{"nct_id":"NCT02770170","title":"Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT05964751","title":"the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT03031925","title":"Detection of Annexin A2 in Systemic Lupus Erythematosus","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT07017868","title":"Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT07363460","title":"Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":105,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT07493655","title":"Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Federal University of Maranhao","has_results":false},{"nct_id":"NCT06837558","title":"Predictors of Bone Mineral Density in Lupus Nephritis Activity","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04218890","title":"TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05097989","title":"Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":100,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04756492","title":"Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04534647","title":"Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Liga Panamericana de Asociaciones de Reumatologia (PANLAR)","has_results":false},{"nct_id":"NCT06167174","title":"Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Chinese SLE Treatment And Research Group","has_results":false},{"nct_id":"NCT06210464","title":"Disease and Biomarker Profiling of Chinese Lupus Nephritis","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Nan Shen","has_results":false},{"nct_id":"NCT03664908","title":"Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"CHU de Reims","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}